{"id":306925,"date":"2019-11-26T21:00:35","date_gmt":"2019-11-27T05:00:35","guid":{"rendered":"https:\/\/nai500.com\/?p=306925"},"modified":"2019-11-26T21:00:58","modified_gmt":"2019-11-27T05:00:58","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e6%96%b0%e9%97%bb%e7%b2%be%e9%80%89-lannett-%e4%b8%8e-hec-%e8%be%be%e6%88%90%e6%96%b0%e7%9a%84%e7%94%98%e7%b2%be%e8%83%b0%e5%b2%9b%e7%b4%a0%e4%ba%a4%e6%98%93","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/11\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e6%96%b0%e9%97%bb%e7%b2%be%e9%80%89-lannett-%e4%b8%8e-hec-%e8%be%be%e6%88%90%e6%96%b0%e7%9a%84%e7%94%98%e7%b2%be%e8%83%b0%e5%b2%9b%e7%b4%a0%e4%ba%a4%e6%98%93\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u65b0\u95fb\u7cbe\u9009\u2014\u2014Lannett\u4e0eHEC\u8fbe\u6210\u65b0\u7684\u7518\u7cbe\u80f0\u5c9b\u7d20\u4ea4\u6613\uff0c\u9ed8\u514b\u516c\u53f8\u7684Keytruda\u5728\u4e2d\u56fd\u53c8\u83b7\u5f97\u4e86\u6279\u51c6"},"content":{"rendered":"

Lannett\u4e0eHEC\u8fbe\u6210\u65b0\u7684\u7518\u7cbe\u80f0\u5c9b\u7d20\u4ea4\u6613<\/h2>\n

Lannett\uff08NYSE\uff1aLCI\uff09<\/a>\u5728\u4e00\u4efd\u6587\u4ef6\u4e2d\u8868\u793a\uff0c\u5b83\u5df2\u4e0eHEC\u7b7e\u8ba2\u4e86\u65b0\u7684\u5408\u4f5c\u548c\u8bb8\u53ef\u534f\u8bae\u3002\u8be5\u534f\u8bae\u53d6\u4ee3\u4e86\u5148\u524d\u5c31HEC\u5728\u7f8e\u56fd\u5f00\u53d1\u3001\u5546\u4e1a\u5316\u548c\u5206\u9500HEC\u7684\u7518\u7cbe\u80f0\u5c9b\u7d20\u4ea7\u54c1\u8fbe\u6210\u7684\u4e24\u9879\u534f\u8bae\u3002<\/p>\n

\u5728\u4ea4\u6613\u4e2d\uff0c\u53cc\u65b9\u5c06\u5171\u540c\u627f\u62c5\u63a7\u5236\u53d1\u5c55\u7684\u8d23\u4efb\uff1bLannett\u5c06\u652f\u4ed8\u9ad8\u8fbe3200\u4e07\u7f8e\u5143\u7684\u5f00\u53d1\u6210\u672c\uff0c\u5e76\u4e14\u53cc\u65b9\u5c06\u5747\u644a\u63a5\u4e0b\u6765\u76841300\u4e07\u7f8e\u5143\u6210\u672c\uff1bHEC\u5c06\u5236\u9020\u4ea7\u54c1\uff0cLanentt\u5c06\u51c6\u5907HEC\u5c06\u63d0\u4ea4\u7684BLA\u5907\u6848\u3002<\/p>\n

\u53e6\u5916\uff1aLannett\u5c06\u6210\u4e3a\u7f8e\u56fd\u7684\u72ec\u5bb6\u5206\u9500\u5546\uff0c\u5e76\u5bf9\u5728\u7f8e\u56fd\u8fdb\u884c\u5546\u54c1\u5316\u8d1f\u5168\u8d23\uff1b\u4e24\u8005\u5c06\u5728\u5934\u5341\u5e74\u5171\u4eab\u5229\u6da6\u548c\u4e8f\u635f\u3002Lannett\u5c06\u62e5\u6709\u4e0e\u4ea7\u54c1\u76f8\u5173\u7684\u67d0\u4e9b\u5df2\u5f00\u53d1\u836f\u7269\u8f93\u9001\u8bbe\u5907\u76f8\u5173\u7684\u77e5\u8bc6\u4ea7\u6743\u3002<\/p>\n

\u52a0\u62ff\u5927\u536b\u751f\u90e8\u5c06\u5ba1\u67e5Knight\u7684Bijuva\u65b0\u836f\u7533\u8bf7<\/h2>\n

\u52a0\u62ff\u5927\u536b\u751f\u90e8\u5df2\u53d7\u7406Knight Therapeutics (OTC:KHTRF)<\/a>BIJUVA\u7684\u65b0\u836f\u7533\u8bf7\u3002BIJUVA\u662f\u96cc\u4e8c\u9187\u548c\u5b55\u916e\u80f6\u56ca\uff0c\u7531TherapeuticsMD\uff08NASDAQ\uff1aTXMD\uff09\u8bb8\u53ef\u7ed9Knight\u8bb8\u53ef\u3002BIJUVA\u65e8\u5728\u6cbb\u7597\u5b50\u5bab\u5b8c\u6574\u7684\u5987\u5973\u4e0e\u7edd\u7ecf\u76f8\u5173\u7684\u4e2d\u5ea6\u81f3\u91cd\u5ea6\u8840\u7ba1\u8212\u7f29\u75c7\u72b6\u3002<\/p>\n

\u9ed8\u514bKeytruda\u518d\u6b21\u5728\u4e2d\u56fd\u83b7\u6279<\/h2>\n

\u9ed8\u514b(NYSE:MRK)<\/a>\u5ba3\uff0cKeytruda\u5df2\u88ab\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u6279\u51c6\u7528\u4e8e\u80ba\u764c\u6cbb\u7597\u3002<\/p>\n

Keytruda\u4e0e\u5316\u5b66\u7597\u6cd5\u8054\u5408\u53ef\u663e\u8457\u6539\u5584\u8f6c\u79fb\u6027\u9cde\u72b6\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u7684\u603b\u751f\u5b58\u671f\u548c\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\u3002<\/p>\n

\u9ed8\u514b\u76d8\u524d\u4e0a\u6da80.53%\u81f3$86.15\u3002<\/p>\n

CCresco Labs\u51fa\u552e\u8d44\u4ea7\u6765\u83b7\u5f97\u66f4\u591a\u8d44\u91d1<\/h2>\n

Cresco Labs (OTCQX:CRLBF)<\/a>\u5ba3\u5e03\u7b7e\u7f72\u4e00\u9879\u5177\u6709\u7ea6\u675f\u529b\u7684\u534f\u8bae\uff0c\u4ee5\u4e70\u5356\u5728\u4fc4\u4ea5\u4fc4\u5dde\u548c\u5bc6\u6b47\u6839\u5dde\u7684\u4e24\u5904\u623f\u4ea7\u3002\u8fd9\u4e9b\u4ea4\u6613\u5c06\u4e3a\u516c\u53f8\u5e26\u6765\u7ea6$3800\u4e07\u7684\u975e\u7a00\u91ca\u6027\u8d44\u91d1\u3002<\/p>\n

Cresco Labs\u8fd8\u5ba3\u5e03\u4e86\u76f8\u4e92\u7ec8\u6b62\u6536\u8d2dVidaCann\u7684\u534f\u8bae\u3002<\/p>\n

Cresco Labs\u9996\u5e2d\u6267\u884c\u5b98Charlie Bachtell\u8bf4\uff1a\u201c\u51ed\u501f\u7075\u6d3b\u5730\u7ee7\u7eed\u5229\u7528\u975e\u7a00\u91ca\u6027\u878d\u8d44\u9009\u62e9\uff0c\u6211\u4eec\u53ef\u4ee5\u7ee7\u7eed\u6267\u884c\u5efa\u7acb\u7f8e\u56fd\u6700\u91cd\u8981\uff0c\u7ecf\u4e45\u4e0d\u8870\u7684\u5927\u9ebb\u516c\u53f8\u7684\u6218\u7565\u3002\u201d<\/p>\n

Boston Scientific\u51fa\u552e\u836f\u7269Zytiga\u7684\u7279\u8bb8\u6743<\/h2>\n

Boston Scientific(NYSE:BSX)<\/a>\u5b50\u516c\u53f8\u4ee5$2.56\u4ebf\u7684\u4ef7\u683c\u5c06\u5176\u4e0eZytiga\u76f8\u5173\u7684\u7279\u8bb8\u6743\u4f7f\u7528\u8d39\u4e2d\u768450%\u51fa\u552e\u7ed9\u4e86\u5b89\u7701\u5e02\u653f\u96c7\u5458\u9000\u4f11\u7cfb\u7edf\u3002<\/p>\n

\u6b64\u6b21\u51fa\u552e\u4e0d\u4f1a\u6539\u53d8\u516c\u53f8\u5bf92019\u5e74\u7684\u9884\u6d4b\u3002<\/p>\n

BSX\u4e8e8\u6708\u901a\u8fc7\u6536\u8d2dBTG\u83b7\u5f97\u4e86Zytiga\u7684\u7279\u8bb8\u6743\u4f7f\u7528\u8d39\u3002Boston Scientific\u8ba1\u5212\u4f7f\u7528\u73b0\u91d1\u507f\u8fd8\u503a\u52a1\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

Lannett (NYSE:LCI) says in a filing that it’s entered into a new collaboration and license agreement with HEC.
\nThe deal replaces an agreement in principle the two previously entered into, with respect to development, commercialization and distribution of HEC’s insulin glargine product in the United States.<\/p>\n","protected":false},"author":9,"featured_media":306922,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,925,459],"class_list":["post-306925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/306925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=306925"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/306925\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/306922"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=306925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=306925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=306925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}